Covidien (COV) Tops Q4 EPS by 13c
Tweet
Share
E-mailGet Alerts COV Hot Sheet
Price: $106.71 --0%
Financial Fact:
Research and development expenses: 133M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development expenses: 133M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Covidien (NYSE: COV) reported Q4 EPS of $1.15, $0.13 better than the analyst estimate of $1.02. Revenue for the quarter came in at $2.73 billion versus the consensus estimate of $2.69 billion.
For earnings history and earnings-related data on Covidien (COV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Wendy's U.S. president to resign, company to create COO role
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
